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Abstract
Background: The aim of this work was to confirm the existence of volatile organic compounds
(VOCs) specifically released or consumed by lung cancer cells.
Methods: 50 million cells of the human non-small cell lung cancer (NSCLC) cell line CALU-1 were
incubated in a sealed fermenter for 4 h or over night (18 hours). Then air samples from the
headspace of the culture vessel were collected and preconcentrated by adsorption on solid
sorbents with subsequent thermodesorption and analysis by means of gas chromatography mass
spectrometry (GC-MS). Identification of altogether 60 compounds in GCMS measurement was
done not only by spectral library match, but also by determination of retention times established
with calibration mixtures of the respective pure compounds.
Results: The results showed a significant increase in the concentrations of 2,3,3-trimethylpentane,
2,3,5-trimethylhexane, 2,4-dimethylheptane and 4-methyloctane in the headspace of CALU-1 cell
culture as compared to medium controls after 18 h. Decreased concentrations after 18 h of
incubation were found for acetaldehyde, 3-methylbutanal, butyl acetate, acetonitrile, acrolein,
methacrolein, 2-methylpropanal, 2-butanone, 2-methoxy-2-methylpropane, 2-ethoxy-2-
methylpropane, and hexanal.
Conclusion: Our findings demonstrate that certain volatile compounds can be cancer-cell derived
and thus indicative of the presence of a tumor, whereas other compounds are not released but
seem to be consumed by CALU-1 cells.
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Analysis of exhaled breath for recognition of human dis-
eases offers the possibility of non-invasive diagnosis [1-4].
This is particularly interesting for critically ill persons [5],
as well as for large scale screening, in the case of renal and
liver diseases [6-10] or for cancer [11-17]. Exhaled air can
be sampled as often as necessary without any restriction.
It may even be done for newborn babies, or patients at the
intensive care unit. Also on-line analysis of exhaled breath
with continuous sampling and analysis of breath is possi-
ble [18-21].
A particularly ambitious goal is a better understanding of
the biochemical background of endogenous compounds
appearing in exhaled breath, both for healthy persons and
persons suffering from certain diseases like cancer. Many
compounds observed in breath have never been discussed
in connection with physiological biochemical processes.
Compounds like 2,2-diethyl-1,1-biphenyl or 2-methyl-1-
(1,1-dimethylethyl)-2-methyl-1,3-propanediyl propanoic
acid ester have been detected [11], which are potentially
interesting but whose underlying biochemistry is com-
pletely unknown.
Better known volatile compounds in exhaled breath are
methanol, ethanol, acetone, acetaldehyde and isoprene.
Even for these compounds, a detailed quantitative under-
standing of production, metabolization and excretion is
not easily available. On-line analysis of exhaled breath
under a challenge (a test on an ergometer with varying
pulse and heart rate, ingestion of food etc.). are promising
and will provide information leading to a better quantita-
tive understanding of biochemical processes within the
human body.
In the present contribution, we turn towards compounds
appearing in exhaled breath of cancer patients. Lung can-
cer patients present a changed pattern of concentration for
many volatile compounds. Some compounds appear in
increased concentration in exhaled breath, some of them
are decreased in concentration [12-14]. For future cancer
screening efforts it will be critical to know which of these
compounds are effectively produced (or consumed) by
cancer cells in the body. Other sources (and sinks) for vol-
atile compounds are immuno-competent cells or micro-
organisms in the gut or the lung. These other sources are
not considered here.
In the study presented here, we focus on a specific cancer
cell line, CALU-1. In the future, we plan to extend our
investigations to primary cells isolated by biopsies or in
the course of a resection from patients themselves. This
would allow a direct comparison of compounds released
(or consumed) by cancer cells and the concentration pat-
terns of volatile compounds in one and the same patient.
Methods
Cell Culture
As lung cancer cell line we tested the human, epithelial
cell line CALU-1 which has been derived from a lung
squamous cell carcinoma. This cell line builds numerous
microvilli, a prominent rough endoplasmatic reticulum,
lysosomes, and lipid inclusions. Furthermore, CALU-1
cells express a mutant K-ras gene. They are grown in
DMEM high glucose (4.5 g/L) culture medium containing
pyruvate (PAA) and supplemented with 10% FCS, penicil-
lin (100 000 units/L), streptomycin (100 mg/L) and L-
glutamine (293 mg/L). Cells were cultivated under stand-
ard conditions in a conventional incubator at 37°C in a
humidified atmosphere with 92.5% air/7.5% CO2. For
VOC measurements 50 millions trypsinized cells were
inoculated in 100 ml phenol red free medium (DMEM
high glucose) in a cell culture fermenter, flushed with
clean, synthetic air taken from a gas cylinder (50 L defined
gas mixture, Linde, Stadl-Paura, Austria) containing 5%
CO2 for at least 10 min at a flow rate of 100 ml/min and
sealed for 4 to 18 h. At the end of the incubation time 200
ml of air from the headspace was used for GC-MS analy-
ses. Cell viability counts (trypan blue exclusion method)
were performed at the end of the incubation period after.
Sampling
Glass tubes (Gerstel, Mülheim an der Ruhr, Germany)
filled with the following sorbents were used as traps for
sample collection with simultaneous preconcentration:
25 mg Tenax TA (60/80 mesh), 35 mg Carboxen 569 (20/
45 mesh), 250 mg Carboxen 1000 (80/100 mesh) (each
from Supelco, Bellefonte, PA, USA). Sorbents were sepa-
rated by glass wool. The sampled air was diluted 1:6 with
dry and additionally purified synthetic air to avoid excess
humidity for thermodesorption. The volume of collected
sample originating from the fermenter was 200 ml with a
total flow through sorption trap of 30 ml/min.
Thermal desorption
The sampled analytes were released from sorbents by ther-
mal desorption in the TDS3 unit equipped with a TDSA2
auto sampler (both from Gerstel, Mülheim an der Ruhr,
Germany). The flow rate of carrier gas through the sorp-
tion trap during desorption was 90 ml/min. The initial
temperature was 30°C and was increased to 300°C by a
heating rate of 100°C/min (held for 10 min). Liquid
nitrogen was used for cryofocusing the desorbed analytes
(-90°C). For subsequent sample injection into the capil-
lary column the CIS-4 injector which contained the glass
liner filled with Carbotrap B (Gerstel, Mülheim an der
Ruhr, Germany) was heated with the rate 12°C/sec up to
320°C (hold 2 min in splitless mode).
GC-MS analyses
The TD-GC-MS analyses were performed on a 6890N gas
chromatograph equipped with a mass selective detectorPage 2 of 11
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Germany) with sample injection by means of thermal des-
orption (described in previous sections). The MS analyses
were performed in a full scan mode, with a scan range of
20–200 amu. Ionization of the separated compounds was
done by electron impact ionization at 70eV. The acquisi-
tion of the chromatographic data was performed by
means of the Agilent Chemstation Software (GC-MS Data
Analysis from Agilent, Waldbronn, Germany) and the
mass spectrum library NIST 2005 (Gatesburg, USA) was
applied for identification. The PoraBond Q capillary col-
umn 25 m × 0,32 mm × 5 μm (Varian, Palo Alto, CA,
USA) was used. The oven temperature program was as fol-
lows: initial 50°C held for 5 min, then ramped 5°C/min
up to 140°C held 5 min, again ramped 5°C/min to
280°C and held for 4 min. The constant flow rate of
helium as a carrier gas was 2 ml/min.
Reagents and standards
2-Butanone, acrolein, methacrolein, 2-ethylacrolein, 2-
methylpropanal, 3-methylbutanal, 2-methylbutanal, 2-
methyl-2-butenal, hexanal, n-butyl acetate, methyl tert-
butyl ether, ethyl tert-butyl ether, 2,4-dimethylpentane,
2,3,4-trimethylpentane, decane and tetrahydrofuran were
each purchased from Sigma-Aldrich (Sigma-Aldrich,
Steinheim, Germany). 2,3,3-Trimethylpentane, 2,3,5-tri-
methylhexane, 2,4-dimethylheptane and 4-methyloctane
were purchased from ChemSampCo (ChemSampCo,
LLC, Trenton, New Jersey, USA), acetaldehyde was pur-
chased from Acros Organics (Acros Organics, Geel, Bel-
gium) and acetonitrile was purchased from J.T. Baker
(Mallinckrodt Baker B.V., Deventer, The Netherlands).
Calibration
For quantification of compounds detected in headspace
of cells and medium solutions the external standard cali-
bration was performed. Preparation of gaseous standards
was performed by evaporation of liquid substances in
glass bulbs. Each bulb (Supelco, Bellefonte, PA, USA) was
cleaned with methanol (Sigma-Aldrich, Steinheim, Ger-
many), dried at 85°C for at least 20 hours, purged with
clean nitrogen for at least 20 min and subsequently evac-
uated using a vacuum pump (Vacuubrand, Wertheim,
Germany) for 30 minutes. Liquid standards (1–3 μL
according to desired concentration) were injected through
a septum, using a GC syringe. After the evaporation of
standards the glass bulb was filled with nitrogen of purity
6.0 (i.e. 99,9999%, Linde, Vienna, Austria) in order to
equalize the pressure (to the ambient pressure). Then the
appropriate volume [μL] of vapour mixture was trans-
ferred using a gas tight syringe (Hamilton, Bonaduz, Swit-
zerland) into Tedlar® bags (SKC 232 Series, Eighty Four,
PA, USA, SKC 232 Series) previously filled with 1,5 L of
nitrogen (99,9999%) additionally purified by means of
carbon molecular sieves (Carboxen 1000).
Results
Identification and quantification of VOCs released by 
CALU-1 cells
Viability after incubation of 50 millions of cells for 4
hours was 98.6 ± 1.1% and after incubation for 18 h 98.7
± 0.7%. Thus, almost no cell death was caused under the
given conditions which ensures that the release of poten-
tial VOCs is mostly due to living and not dying cells.
Among all detected compounds we observed altogether
60 substances that could be identified not only by spectral
library match using NIST 2005 library but also by determi-
nation of retention time based on calibration mixtures of
the respective pure compound (Table 1A). An exemplary
chromatogram of the headspace of CALU-1 cancer cells is
presented in Figure 1. The substances, for which identifi-
cation was done only by means of spectral library match
without confirmation of their retention times, are listed in
Table 1B. The peaks for which the proper identification
was not possible (too low library match and no confirma-
tion by retention time) are not discussed at all. Generally,
the applied TD-GC-MS method is characterized by good
linearity (even for the lowest detected concentrations)
with correlation coefficients being mostly higher than
0,99. The LODs for almost all compounds were as low as
pptv level. The lowest LOD was observed for 2,3,3-tri-
methylpentane (127 pptv = 5,725*10-4 μg/l) and 2,3,5-tri-
methylhexane (137 pptv = 7,583*10-4 μg/l) but also polar
compounds exhibited very low detection limits, e.g. 2-
methylpropanal (143 pptv = 3,912*10-4 μg/l) and ace-
tonitrile (147 pptv = 1,166*10-7 μg/l). Only two com-
pounds of interest with LOD at the level of single ppbv
(the highest observed values) were acetaldehyde (1,517
ppbv = 1,312*10-3 μg/l), and 4-methyloctane (1,168 ppbv
= 5,578*10-3 μg/l). More detailed informations are listed
in Tables 2 and 3A-B). Such low limits of detection with
simultaneous low errors (expressed by correlation coeffi-
cients) testify very good precision and sensitivity of the
applied TD-GC-MS method.
TD-GC-MS analyses of the headspace of CALU-1 cells
In three independent experiments using TD-GC-MS after
preconcentration of sampled air by means of adsorption
on solid sorbents, the concentrations of 4 compounds
could be shown to be increased (Table 2) and other 12
compounds to be decreased (Table 3A and 3B) in the
headspace of CALU-1 cells as compared to the headspace
of medium only. These compounds are those which were
detected in all measured samples of cancer cells as well as
medium. All other 44 (= 60-16) identified compounds are
not discussed in detail since they appeared "irregularly",
i.e., not consistently increased or decreased with respect to
medium only. The only exception is 2-methyl-2-butenal
which was always found > LOD in cell culture medium
samples whereas its concentration was below LOD inPage 3 of 11
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small sample population, statistical tests should not be
used. Instead, the direct comparison of VOCs concentra-
tion detected in cell and medium samples was done. We
discuss only those compounds which are present in every
CALU1 cell sample at (consistently) higher or (consist-
ently) lower level than in every medium sample. Ratios of
mean concentrations from both kinds of samples are
given in Tables 2 and 3A–B.
After 4 hours of incubation in the fermenter an increase of
isopropyl alcohol could be found. However, concentra-
tion of 2-propanol increased in only 3 from 4 measure-
ments with 4 h incubation, whereas for the samples
incubated 18 h there is no significant difference between
the measured amount of 2-propanol in headspace of can-
cer cells and in headspace of medium. After 18 h of incu-
bation 2,3,3-trimethylpentane (mean ppbv in cells/mean
ppbv in medium = 1,89), 2,3,5-trimethylhexane (1,71),
2,4-dimethylheptane (3,04) and 4-methyloctane (1,71)
were increased significantly in the headspace of CALU-1
cells (Figure 2). Decreased concentrations from cancer
cells after 4 h were found for the compounds methacro-
lein (0,10), 2-methylpropanal (0,08), 2-methoxy-2-meth-
ylpropane (0,39), 3-methylbutanal (0,01), 2-methyl-2-
butenal (0) and n-butyl acetate (0,14) (Figure 3 and Fig-
ure 4A). After 18 h of incubation acetaldehyde (mean
ppbv in cells/mean ppbv in medium = 0,22), acetonitrile
(0,48), acrolein (0,57), methacrolein (0,12), 2-methyl-
propanal (0,07), 2-butanone (0,47), 2-methoxy-2-meth-
ylpropane (0,41), 3-methylbutanal (0,01), 2-methyl-2-
butenal (0), 2-ethoxy-2-methylpropane (0,40), hexanal
(0,37) and n-butyl acetate (0,17) were decreased signifi-
cantly (Figure 3 and Figure 4B).
Discussion
In our experiments VOCs released from the lung cancer
cell line CALU-1 were collected and preconcentrated by
means of adsorption on solid sorbents with subsequent
thermal desorption and analysis by GC-MS. In investiga-
tions with the cell line CALU-1 longer and shorter incuba-
tion times (18 h and 4 h respectively) were tested whereas
in earlier experiments a technical device and a protocol for
this experimental setting had to be developed.
The results of experiments with CALU-1 cells confirmed
the existence of compounds that are either released or
consumed by these cells. Discussed are only these analytes
which were detected in all samples of medium as well as
cancer cells. Furthermore, it is indicated that the release of
compounds can be detected after prolonged incubation
time but so far no significant release after 4 hours of incu-
bation could be observed. On the other hand, consump-
tion of several aldehydes as well as n-butyl acetate and
methyl tert-butyl ether from the headspace of cells solu-
tion could be detected already after a short period of incu-
bation. Even for the compounds like acetaldehyde and
especially 3-methylbutanal and n-butyl acetate that are
based on high background from medium, a strong reduc-
tion of concentration was observed after only 4 hours of
incubation (Table 3A). The influence of incubation time
on the amount of detected compounds is illustrated in
Figure 3. Because of big variations in measured peak areas
of acetaldehyde the significance for this compound was
An exemplary chromatogram of volatile compounds in headspace of the cancer cells CALU-1Figur  1
An exemplary chromatogram of volatile compounds in headspace of the cancer cells CALU-1. 200 ml of head-
space from cells cultured in 100 ml medium were collected on a sorption trap filled with Tenax TA, Carboxen 569, Carboxen 
1000 and subsequently thermal desorbed into the GC-MS system. The peaks that correspond to compounds discussed in this 
paper are labeled with letters (see Table 1). Peaks exceeding the range of scale are cut off.Page 4 of 11
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A: Summary of all substances identified by spectral match and confirmation of retention time
No. Compound tR [min] CAS
1 Methyl alcohol 8,778 67-56-1
2 Dimethyl ether 10,323 115-10-6
3 Acetaldehyde 11,936 75-07-0
4 Methanethiol 13,130 74-93-1
5 Isobutane 15,785 75-28-5
6 2-Methyl-1-propene 16,118 115-11-7
7 Ethyl alcohol 16,517 64-17-5
8 Acetonitrile (a) 17,423 75-05-8
9 2-Butene (Z or E isomer) 17,009 107-01-7
10 Butane 17,186 106-97-8
11 2-Butene (E or Z isomer) 17,360 115-11-7
12 2-Propenal (b) 19,310 107-02-8
13 Furan 19,741 110-00-9
14 Propanal 20,170 123-38-6
15 Acetone 20,469 67-64-1
16 Isopropyl Alcohol 21,720 67-63-0
17 2-Methylbutane 23,229 78-78-4
18 Ethyl ether 23,503 60-29-7
19 1-Propanol 23,696 71-23-8
20 Pentane 24,224 109-66-0
21 Methacrolein (c) 25,375 78-85-3
22 2-Methylpropanal (d) 25,917 78-84-2
23 Methyl vinyl ketone 26,795 78-94-4
24 Trichloromethane 27,561 67-66-3
25 Tetrahydrofuran 27,920 109-99-9
26 2-Butanone (e) 28,124 78-93-3
27 Ethyl acetate 29,829 141-78-6
28 2-Methoxy-2-methylpropane (f) 30,377 1634-04-4
29 2-Methyl-1-pentene 31,692 763-29-1
30 Benzene 32,418 71-43-2
31 Hexane 33,003 110-54-3
32 2-Ethylacrolein 34,049 922-63-4
33 3-Methylbutanal (g) 34,587 590-86-3
34 2-Ethoxy-2-methylpropane (h) 35,346 637-92-3
35 2-Pentanone 35,868 107-87-9
36 Methyl methacrylate 36,121 80-62-6
37 2-Methyl-2-butenal 37,277 1115-11-3
38 3-Methylhexane 38,434 589-34-4
39 Cyclopentanone 38,750 120-92-3
40 Toluene 39,466 108-88-3
41 Furfural 40,044 98-01-1
42 Methyl isobutyl ketone 40,262 108-10-1
43 Hexanal (i) 42,001 66-25-1
44 Butyl acetate (j) 42,624 123-86-4
45 2,3,4-Trimethylpentane 42,949 565-75-3
46 2,3,3-Trimethylpentane (k) 43,202 560-21-4
47 4-Methylheptane 43,385 589-53-7
48 3-Ethylhexane 43,580 619-99-8
49 Octane 44,465 111-65-9
50 p-Xylene 44,721 106-42-3
51 Styrene 45,195 100-42-5
52 p-Xylene 45,363 106-42-3
53 3-Methyl-2(5H)-furanone 45,779 22122-36-7
54 2,3,5-Trimethylhexane (l) 46,456 1069-53-0
55 2,4-Dimethylheptane (m) 46,647 2213-23-2
56 Benzaldehyde 46,799 100-52-7
57 4-Methyloctane (n) 47,697 2216-34-4
58 Octanal 50,921 124-13-0Page 5 of 11
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can be observed.
Interestingly, the results of our experiments showed that
the majority of detected volatile substances which are sig-
nificantly increased in the headspace of cell culture com-
pared to medium control are saturated hydrocarbons.
From CALU-1 cells 2,3,3-trimethylpentane, 2,3,5-trimeth-
ylhexane, 2,4-dimethylheptane and 4-methyloctane were
released (Figure 2). The measured concentrations of these
compounds are listed in Table 2. In the group of Phillips
et al. it was found that several alkanes and branched
hydrocarbons including also 4-methyloctane were
increased in the breath of lung cancer patients compared
to healthy persons [12,13].
Because of the high concentrations of target compounds
in the medium, the difference between their amount in
cell and in medium headspace samples is rather low.
Moreover, although release of some compounds seems to
be observed, background peak areas are considerably dif-
ferent in independent experiments which results in high
standard deviation. Thus direct comparison of measured
amounts is not precise. The compounds already present in
the headspace of culture medium may, in particular, orig-
inate from fetal calf serum added to culture medium.
Thus, to reduce background one option would be to use
medium without serum or to reduce serum to low concen-
trations. However, preliminary experiments indicated a
loss of VOC release under low serum cell culture condi-
tions, possibly due to different metabolism of the cell line
used. Thus to achieve lower background level we reduced
fetal calf serum but only to 5%.
The metabolic origin of the detected substances so far
remains speculative. In the present experiments we
observed saturated as well as branched hydrocarbons,
which corroborates clinical studies which demonstrate
exhalation of hydrocarbons.
We observed that acetaldehyde is consumed by CALU-1
cells (Figure 3). This fact is contradictory to the work of
Table 2: Quantification of VOCs released from CALU-1 cancer cells after adsorption on solid sorbents with subsequent TD-GC-MS 
analyses.











Compound CAS R2 LOD 
[ppbv]
Medium Cells
2,3,3-trimethylpentane 560-21-4 0,998 0,127 0,37 0,45 0,40 0,60 0,84 0,86 0,41 0,77 1,89
2,3,5-trimethylhexane 1069-53-0 0,997 0,149 0,43 0,42 0,29 0,79 0,67 0,50 0,38 0,65 1,71
2,4-dimethylheptane 2213-23-2 0,996 0,179 0,33 0,35 0,20 1,25 0,77 0,65 0,29 0,89 3,04
4-methyloctane 2216-34-4 0,985 1,168 1,33 1,51 2,02 4,03 2,09 2,17 1,62 2,76 1,71
The concentrations of these VOCs are increased in headspace of CALU-1 cells in comparison with medium only, after 18 hours of incubation. The 
concentrations of discussed VOCs are given for each measured sample (headspace of CALU-1 cells and of medium). The correlation coefficients 
(for calibration experiments) and the limits of detection (LODs) are presented.
59 Limonene 52,217 138-86-3
60 Decane 52,572 124-18-5
Listed are substances observed in the headspace of medium as well as in the headspace of CALU-1 cancer cells. Letters in parentheses refer to 
peaks shown in the chromatogram of Figure 1.
B: List of compounds identified only by means of spectral library match
Compound tR [min] CAS M+.
Propene 7,939 115-07-1 42
Chloromethane 8,259 74-87-3 50
Acetophenone 51,165 98-86-2 120
(1E)-1-Butenylbenzene 53,069 824-90-8 132
Nonanal 54,630 124-19-6 144
Listed are compounds detected in the headspace of medium and CALU-1 cancer cells. Relative molecular mass (RMM) of the suspected molecular 
ion is given for each presented compound.
Table 1:  (Continued)Page 6 of 11
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dehyde released from CALU-1 and SK-MES cells, also a
lung cancer cell line [22]. The reason or reasons for this
completely opposite behavior of CALU-1 cells, concern-
ing the metabolism of acetaldehyde are unclear. In litera-
ture acetaldehyde is described as the first metabolic
product of alcohol metabolism in vivo [23] and as carcino-
genic.
Besides acetaldehyde several other compounds are con-
sumed or taken up by the cells whereby especially alde-
hydes have decreased concentrations compared to
medium control (see Table 3A and 3B and Figures 4A and
4B). As for acetaldehyde the mechanism of consumption
of those substances by the cells has to be elucidated. How-
ever, the degradation or consumption of aldehydes may
be partly explained by an increased activity of aldehyde
dehydrogenases. For instance, aldehyde dehydrogenase 1
was found to be a marker of breast cancer cells [24] and
was found to be increased in the lung cancer cell line A549
[25]. Moreover, in a work of Patel et al. [26] significantly
higher expression levels of aldehyde dehydrogenase 1A1
and aldehyde dehydrogenase 3A1 were detected in squa-
mous cell cancer, adenocarcinoma, and small cell lung
cancer. In this work it was shown that atypical pneumo-
cytes demonstrated significantly higher levels of expres-
sion of aldehyde dehydrogenase 1A1 and aldehyde
dehydrogenase 3A1 than normal pneumocytes (a normal
counterpart of adenocarcinoma), which is suggestive of
up regulation during malignant transformation to adeno-
carcinoma. It was also found that non-small cell lung can-
cer expresses very high levels of aldehyde dehydrogenase
1A1 and aldehyde dehydrogenase 3A1 in comparison
with small cell lung cancer. Thus, elevated expression of
both enzymes may be associated with malignant transfor-
mation to adenocarcinoma. Those data would point out a
putative metabolic mechanism of degradation of alde-
hydes which was observed in this work.
Table 3: A and B: Quantification of VOCs consumed by CALU-1 cancer cells after adsorption on solid sorbents with subsequent TD-
GC-MS analyses.
A










Compound CAS R2 LOD 
[ppbv]
Medium Cells
methacrolein 78-85-3 0,999 0,466 5,66 9,38 3,93 0,63 0,34 0,84 0,34 0,34 4,898 0,469 0,10
2-methylpropanal 78-84-2 0,998 0,143 19,80 12,98 39,53 9,12 1,21 below 
LOD
3,35 2,03 20,357 1,649 0,08
methyl tert-butyl 
ether
1634-04-4 0,999 0,293 1,68 3,43 3,56 1,60 0,67 0,94 1,30 1,11 2,567 1,004 0,39
3-methylbutanal 590-86-3 0,994 0,234 142,29 184,19 218,74 73,14 0,08 2,44 3,02 2,13 154,588 1,916 0,01
n-butyl acetate 123-86-4 0,999 0,134 60,47 105,13 66,58 58,08 2,01 14,70 11,27 13,08 72,566 10,267 0,14
B
Compound CAS R2 LOD 
[ppbv]





















81,692 302,803 66,054 0,22
acetonitrile 75-05-8 0,998 0,147 11,344 7,540 5,764 4,183 3,633 4,100 8,216 3,972 0,48
acrolein 107-02-8 0,998 0,718 5,703 3,462 4,079 2,185 2,071 3,238 4,415 2,498 0,57
methacrolein 78-85-3 0,999 0,466 5,933 4,975 4,723 0,811 0,344 0,702 5,210 0,619 0,12
2-methylpropanal 78-84-2 0,998 0,143 30,915 11,773 21,277 0,532 3,573 0,083 21,322 1,396 0,07
2-butanone 78-93-3 0,999 0,149 3,523 5,206 3,084 1,114 2,812 1,669 3,938 1,865 0,47
methyl tert-butyl 
ether
1634-04-4 0,999 0,293 2,126 4,202 2,089 0,753 1,654 1,023 2,806 1,143 0,41




78,027 2,226 2,215 1,529 147,461 1,990 0,01
ethyl tert-butyl ether 637-92-3 0,999 0,215 6,168 11,281 5,121 2,060 4,805 2,229 7,523 3,032 0,40







hexanal 66-25-1 0,981 0,540 2,043 2,805 1,980 0,791 1,016 0,711 2,276 0,839 0,37
n-butyl acetate 123-86-4 0,999 0,134 43,949 31,381 26,348 11,084 3,032 3,324 33,892 5,813 0,17
The concentration of these VOCs is decreased in headspace of CALU-1 cells in comparison with medium only. Two different incubation times 
were studied: 4 h (A) and 18 h (B). The concentrations of discussed VOCs are given for measured sample (headspace of CALU-1 cells and of 
medium). The correlation coefficients (for calibration experiments) and the limits of detection (LODs) are presented.Page 7 of 11
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Comparison of VOCs concentrations present at higher concentration in the headspace of CALU-1 cells in culture (blue col-umns) as compared to medium control (red columns) after 18 h of incubationFigure 2
Comparison of VOCs concentrations present at higher concentration in the headspace of CALU-1 cells in cul-
ture (blue columns) as compared to medium control (red columns) after 18 h of incubation. Presented are aver-
age concentrations (n = 3) with standard deviations. Significant differences are labeled with asterisks.
Comparison of VOCs present at lower concentrations present in the headspace of cells in culture (CALU-1) (bright blue and dark blue columns) a compared t  medium control (yellow and red columns) after 4 h a d 18 h of incubationFigure 3
Comparison of VOCs present at lower concentrations present in the headspace of cells in culture (CALU-1) 
(bright blue and dark blue columns) as compared to medium control (yellow and red columns) after 4 h and 18 
h of incubation. Presented are average concentrations (n = 4 for 4 h of incubation, n = 3 for 18 h of incubation) with stand-
ard deviations. Significant differences are labeled with asterisks.
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A and BFigure 4
A and B: Comparison of VOCs concentrations present at lower level in the headspace of cell culture (CALU-1) 
solution (blue columns) as compared with medium only (red columns) after 4 h (Fig. 4A) and 18 h (Fig. 4B) of 
incubation. Presented are average concentrations (n = 4 for 4 h of incubation, n = 3 for 18 h of incubation) with standard 
deviation. Significant differences are labeled with asterisks.
Cancer Cell International 2008, 8:17 http://www.cancerci.com/content/8/1/17Conclusion
This work is a first step to get a better understanding on
the metabolism of VOCs from cancer cells. We found that
2,3,3-trimethylpentane, 2,3,5-trimethylhexane, 2,4-
dimethylheptane and 4-methyloctane are released from
the cell line CALU-1 and therefore should be taken into
account as possible tumor-related compounds. It was also
clearly shown that these cells are consuming several types
of aldehydes but also compounds from other classes.
Decreased level of aldehydes can be partly explained by
higher activity of aldehyde dehydrogenase in cancer cells.
Summarizing, these investigations give some hints which
substances are candidates for biomarkers of cancer disease
and thus may finally provide a technically feasible
method for early and non-invasive diagnosis of lung can-
cer. However, biochemical background of all discussed
compounds should be elucidated before using them as
fully assured biomarkers.
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